Elevated Capital Advisors, LLC

SEC CIK: 0001802387
Latest filing: Aug 3, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Elevated Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 5
Value: $3.12K
% of portfolio: <0.1%
Quarters held: 4; Since Q1 2021

Holdings of REGN by Elevated Capital Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	5	$3.12K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	5	$3.86K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	5	$3.86K	<0.1%	+5	New	Holders
Q2 2021	–	–	–	–	Not filed	Holders
Q1 2021	1,956	$987.0K	0.4%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.